When did Perspective Therapeutics report Q3 2024 earnings?

Perspective Therapeutics (CATX) reported Q3 2024 earnings on November 12, 2024 before market open.

What were Perspective Therapeutics's Q3 2024 revenue and EPS?

Perspective Therapeutics reported revenue of $369.0K and eps of $-0.21 for Q3 2024.

Did Perspective Therapeutics beat estimates in Q3 2024?

Revenue beat the consensus estimate of $292.8K by $76.2K. EPS beat the consensus estimate of $-0.21 by $0.00.

Where can I find Perspective Therapeutics's Q3 2024 SEC filings?

You can read the 10-Q periodic report (0000950170-24-125399) directly on SEC EDGAR. The filing index links above go to sec.gov.

Perspective Therapeutics CATX Q3 2024 earnings

Reported November 12, 2024 · Before market open

Revenue$369.0KBeat by $76.2K

EPS-$0.21In line

Revenue estimate$292.8K

EPS estimate-$0.21

Next report

Aug 12, 2026 (In 1 week)

Revenue estimate$90.5K

EPS estimate-$0.27

Financials

Q3 2024

Income statement

See full

Operating income-$18.6M-91.1%

Net income-$15.1M-46.0%

EPS (diluted)-$0.21+43.2%

Balance sheet

See full

Cash & equivalents$226.4M+1,159%

Total debt$4.2M+29.4%

Total equity$328.5M+233%

Total assets$391.2M+254%

Cash flow

See full

Operating cash flow$3.4M+133%

CapEx$29.7M+12,989%

Free cash flow-$26.3M-155%

Valuation & ratios

Valuation

as of 09/30/24

See full

Market cap$900.16M+1,072%

Enterprise value$677.93M+992%

Returns & leverage

See full

Return on equity-29.9%+2.2pp

Debt / equity0×0.0×

Current ratio9.6×+6.9×

Versus estimates

Revenue

Q1 2026$76.0KMiss by $81.4K Q4 2025$43.0KMiss by $189.5K Q2 2025$234.0KBeat by $59.4K Q1 2025$342.0KBeat by $156.1K Q4 2024$234.0KMiss by $43.3K

Q3 2024$369.0KBeat by $76.2K

Diluted EPS

Q1 2026-$0.25Beat by $0.04 Q4 2025-$0.51Miss by $0.14 Q2 2025-$0.30In line Q1 2025-$0.25Beat by $0.03 Q4 2024-$0.25Beat by $0.01

Q3 2024-$0.21In line

Ask the moment Perspective Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Perspective Therapeutics report Q3 2024 earnings?: Perspective Therapeutics (CATX) reported Q3 2024 earnings on November 12, 2024 before market open.
What were Perspective Therapeutics's Q3 2024 revenue and EPS?: Perspective Therapeutics reported revenue of $369.0K and eps of $-0.21 for Q3 2024.
Did Perspective Therapeutics beat estimates in Q3 2024?: Revenue beat the consensus estimate of $292.8K by $76.2K. EPS beat the consensus estimate of $-0.21 by $0.00.
Where can I find Perspective Therapeutics's Q3 2024 SEC filings?: You can read the 10-Q periodic report (0000950170-24-125399) directly on SEC EDGAR. The filing index links above go to sec.gov.